Institutions collaborate to produce new type of malaria vaccine

01/25/2010 | Gazette (Gaithersburg, Md.), The

The Malaria Vaccine Initiative has partnered with the Johns Hopkins Bloomberg School of Public Health and the Sabin Vaccine Institute to produce a malaria vaccine that would seek to stop the mosquito-human-mosquito disease transmission cycle. The vaccine would be administered to uninfected people and to those who have already been infected by the disease, a researcher said. Antibodies produced through the vaccine would prevent a mosquito that bit the vaccinated person from producing the malaria parasite in its gut, thus preventing transmission to another person.

View Full Article in:

Gazette (Gaithersburg, Md.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX